Research develops a liquid crystal aptasensor that detects PDGF-BB in human serum, indicating its potential for tumor diagnostics.
A liquid crystal (LC)-based dielectric aptasensor was developed for the sensitive and selective detection of tumor biomarker, platelet-derived growth factor (PDGF-BB). The LC aptasensor was prepared by immobilization of PDGF-BB specific aptamer on silane modified patterned indium-tin-oxide-glass substrates of the LC cell through a cross linker, glutaraldehyde. Frequency-dependent dielectric measurements were carried out with the 4-cyano-4′-pentylbiphenyl LC material in an aptasensor with electrodes pretreated with different concentrations of PDGF-BB spiked human serum. A significant change in the dielectric property was observed corresponding to the disruption of uniform homeotropic LC alignment at LC–electrode interface, caused by accumulated bulky charged species due to PDGF-BB binding with aptamer at the electrode surface. The LC aptasensor cell exhibited a linear response in relative dielectric permittivity (Δεr′) at 100 Hz with PDGF-BB over a wide concentration range of 10 pM to 100 nM with a lowest detection limit of 4.8 pM. The experimental data fitted well with the Cole–Cole model of dielectric relaxation showed a gradual increase in LC dielectric strength with increasing concentration of PDGF-BB binding to aptamer at ˂10 kHz, suggesting a dominant surface interfacial phenomenon than bulk molecular process at higher frequency. The LC aptasensor cell exhibited either minimal or insignificant dielectric response to other PDGF isoforms, viz. PDGF-AB and PDGF-AA, and other potential interferents, revealing high specificity to PDGF-BB. The present study demonstrated that the proposed concept of dielectric LC aptasensor may find potential application in tumor detection.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: